Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.99 USD | -0.81% | +33.52% | +47.29% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
Financials (USD)
Sales 2024 * | 551M | Sales 2025 * | 587M | Capitalization | 2.37B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -193M | EV / Sales 2024 * | 3.91 x |
Net cash position 2024 * | 212M | Net Debt 2025 * | 234M | EV / Sales 2025 * | 4.43 x |
P/E ratio 2024 * |
-13.8
x | P/E ratio 2025 * |
-12.5
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.74% |
Latest transcript on NovoCure Limited
1 day | -0.81% | ||
1 week | +33.52% | ||
Current month | +79.66% | ||
1 month | +82.49% | ||
3 months | +36.25% | ||
6 months | +77.77% | ||
Current year | +47.29% |
Managers | Title | Age | Since |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01-12-31 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 14-05-31 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 03-12-31 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 11-08-04 |
David Hung
BRD | Director/Board Member | 66 | 18-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.81% | 0 M€ | 0.00% | - | |
0.71% | 0 M€ | 0.00% | - | |
0.19% | 17 M€ | +7.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 21.99 | -0.81% | 1,150,859 |
24-05-16 | 22.17 | +5.32% | 1,633,139 |
24-05-15 | 21.05 | +3.59% | 2,170,581 |
24-05-14 | 20.32 | +13.01% | 2,752,228 |
24-05-13 | 17.98 | +9.17% | 1,514,092 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.29% | 2.37B | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+5.88% | 6.59B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- NVCR Stock